Hepatic HuR modulates lipid homeostasis in response to high-fat diet
暂无分享,去创建一个
R. de Cabo | M. Gorospe | Wengong Wang | Y. Dou | Jichun Yang | Z. Ju | Changtao Jiang | Lijun Zhu | Zhongzhou Yang | X. Yi | Bin Jiang | Zhuojun Zhang | Jinfan Li | C. Zong | Congxiu Miao | Ming-Wen Chang | Feng Tian | Xueping Xiang | Xiaolei Cheng | Wen Su | Mingyang Jiang | Han Hu | Juhua Ni | Xia Yi
[1] Z. Younossi. Non-alcoholic fatty liver disease - A global public health perspective. , 2019, Journal of hepatology.
[2] Ji Yuan,et al. Endothelial HuR deletion reduces the expression of proatherogenic molecules and attenuates atherosclerosis , 2018, International immunopharmacology.
[3] R. Tayyem,et al. Non-alcoholic fatty liver disease and associated dietary and lifestyle risk factors. , 2018, Diabetes & metabolic syndrome.
[4] M. Bennett,et al. Restoring mitochondrial DNA copy number preserves mitochondrial function and delays vascular aging in mice , 2018, Aging cell.
[5] Oliver D. K. Maddocks,et al. Serine and Functional Metabolites in Cancer. , 2017, Trends in cell biology.
[6] Marvin N. Wright,et al. Low-level mitochondrial heteroplasmy modulates DNA replication, glucose metabolism and lifespan in mice , 2017, bioRxiv.
[7] M. Gorospe,et al. RNA-binding proteins regulate cell respiration and coenzyme Q biosynthesis by post-transcriptional regulation of COQ7 , 2016, RNA biology.
[8] G. Weber. Metabolism in cancer metastasis , 2016, International journal of cancer.
[9] Liying Li,et al. Essential Roles of RNA-binding Protein HuR in Activation of Hepatic Stellate Cells Induced by Transforming Growth Factor-β1 , 2016, Scientific Reports.
[10] M. Gorospe,et al. NSun2 delays replicative senescence by repressing p27 (KIP1) translation and elevating CDK1 translation , 2015, Aging.
[11] M. Soller,et al. Concentration and Localization of Coexpressed ELAV/Hu Proteins Control Specificity of mRNA Processing , 2015, Molecular and Cellular Biology.
[12] E. Levy. Insights from human congenital disorders of intestinal lipid metabolism , 2015, Journal of Lipid Research.
[13] I. Kotta-Loizou,et al. Clinical significance of HuR expression in human malignancy , 2014, Medical Oncology.
[14] M. Gorospe,et al. RNA binding protein HuR regulates the expression of ABCA1[S] , 2014, Journal of Lipid Research.
[15] Yael Mandel-Gutfreund,et al. RBPmap: a web server for mapping binding sites of RNA-binding proteins , 2014, Nucleic Acids Res..
[16] B. Fromenty,et al. Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease , 2013, Hepatology.
[17] J. Keene,et al. Mechanisms coordinating ELAV/Hu mRNA regulons. , 2013, Current opinion in genetics & development.
[18] Wengong Wang. Regulatory RNA-binding proteins in senescence , 2012, Ageing Research Reviews.
[19] K. Adeli. Translational control mechanisms in metabolic regulation: critical role of RNA binding proteins, microRNAs, and cytoplasmic RNA granules. , 2011, American journal of physiology. Endocrinology and metabolism.
[20] Kotb Abdelmohsen,et al. Posttranscriptional regulation of cancer traits by HuR , 2010, Wiley interdisciplinary reviews. RNA.
[21] Shelly C. Lu,et al. HuR/methyl-HuR and AUF1 regulate the MAT expressed during liver proliferation, differentiation, and carcinogenesis. , 2010, Gastroenterology.
[22] M. Gorospe,et al. Reduced nuclear export of HuR mRNA by HuR is linked to the loss of HuR in replicative senescence , 2009, Nucleic acids research.
[23] Caiying Guo,et al. Essential role of the RNA-binding protein HuR in progenitor cell survival in mice. , 2009, The Journal of clinical investigation.
[24] Hirokazu Takahashi,et al. Dysfunctional very‐low‐density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis , 2009, Hepatology.
[25] Adrian R Krainer,et al. Splicing therapeutics in SMN2 and APOB. , 2009, Current opinion in molecular therapeutics.
[26] F. Bellanti,et al. Alterations of hepatic ATP homeostasis and respiratory chain during development of non‐alcoholic steatohepatitis in a rodent model , 2008, European journal of clinical investigation.
[27] J. Weiss,et al. Thematic review series: Systems Biology Approaches to Metabolic and Cardiovascular Disorders. Network perspectives of cardiovascular metabolism Published, JLR Papers in Press, August 31, 2006. , 2006, Journal of Lipid Research.
[28] I. Goldberg,et al. Ins and outs modulating hepatic triglyceride and development of nonalcoholic fatty liver disease. , 2006, Gastroenterology.
[29] M. Gorospe,et al. Translational Control of Cytochrome c by RNA-Binding Proteins TIA-1 and HuR , 2006, Molecular and Cellular Biology.
[30] P. Nilsson-ehle,et al. Influence of liver cancer on lipid and lipoprotein metabolism , 2006, Lipids in Health and Disease.
[31] J. Jessurun,et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. , 2005, The Journal of clinical investigation.
[32] A. Cederbaum,et al. A high‐fat diet leads to the progression of non‐alcoholic fatty liver disease in obese rats , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[33] J. Arenas,et al. Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis , 2003, Hepatology.
[34] E. Fisher,et al. Complexity in the Secretory Pathway: The Assembly and Secretion of Apolipoprotein B-containing Lipoproteins* , 2002, The Journal of Biological Chemistry.
[35] D. Kardassis,et al. Transcriptional regulatory mechanisms of the human apolipoprotein genes in vitro and in vivo , 2001, Current opinion in lipidology.
[36] T Hashimoto,et al. Defect in Peroxisome Proliferator-activated Receptor α-inducible Fatty Acid Oxidation Determines the Severity of Hepatic Steatosis in Response to Fasting* , 2000, The Journal of Biological Chemistry.
[37] M Sullivan,et al. Identification and Characterization of a 315-Base Pair Enhancer, Located More than 55 Kilobases 5′ of the Apolipoprotein B Gene, That Confers Expression in the Intestine* , 2000, The Journal of Biological Chemistry.
[38] C. Baird. The pilot study. , 2000, Orthopedic nursing.
[39] H. Cortez‐Pinto,et al. Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study. , 1999, JAMA.
[40] J. Borén,et al. The assembly and secretion of apolipoprotein B-containing lipoproteins. , 1999, Current opinion in lipidology.
[41] J. Borén,et al. Influence of triacylglycerol biosynthesis rate on the assembly of apoB-100-containing lipoproteins in Hep G2 cells. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.
[42] J. Folch,et al. A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.
[43] Kotb Abdelmohsen,et al. Posttranslational control of HuR function , 2017, Wiley interdisciplinary reviews. RNA.
[44] Michael P. Lisanti,et al. Cancer metabolism: a therapeutic perspective , 2017, Nature Reviews Clinical Oncology.
[45] Myriam Gorospe,et al. HuR function in disease. , 2012, Frontiers in bioscience.
[46] J. Weiss,et al. Network perspectives of cardiovascular metabolism , 2006 .
[47] T. Hashimoto,et al. PEROXISOMAL β-OXIDATION AND PEROXISOME PROLIFERATOR–ACTIVATED RECEPTOR α: An Adaptive Metabolic System , 2001 .
[48] R. Havel,et al. Lipoproteins and lipid transport. , 1975, Advances in experimental medicine and biology.
[49] C. Williamson,et al. Therapeutic perspective. , 1951, California medicine.